By integrating its automated care navigation platform with Bluestream’s digital front door platform, eVisit aims to offer a streamlined interface.
Virtual care company eVisit acquires Bluestream Health Read More »
The agency alleges that hospitals in Missouri and Kansas violated EMTALA by failing to provide needed care to a woman whose pregnancy became nonviable at 18 weeks.
CMS launches investigations into denied emergency abortion care Read More »
Stryker CEO Kevin Lobo named the Mako robot as a driver of “pretty breathtaking” knee growth outside the U.S.
Analyst ‘blown away’ by robot-fueled growth of Stryker’s hip and knee sales Read More »
The breast health unit “emphatically returned to growth” because of improvements to the supply of semiconductors.
Hologic, after overcoming chip shortage, starts considering larger M&A deals Read More »
Scientists must act differently than other professionals to build a successful personal brand on social media. Check out our comprehensive guide to get started.
A Scientist’s Guide to Social Media: Using the Internet to Build a Personal Brand Read More »
Tay Therapeutics, focused on developing small molecules for oncology and severe inherited diseases, today announced that it has entered into an exclusive license agreement with VYNE Therapeutics Inc. (Nasdaq: VYNE),
Cyclo Therapeutics, Inc. today announced that it has closed a private placement of its securities with Rafael Holdings, Inc. (NYSE:RFL) (“Rafael”) for the purchase of 2,514,970 shares of common stock and warrants.
NeuroSense Therapeutics Ltd. today announced positive preliminary results from a novel biomarker study conducted to evaluate the potential of NeuroSense’s combination platform therapy for the treatment of Parkinson’s disease (PD), the second most common neurodegenerative disorder.
Bryn Pharma, LLC announced today the addition of three new executives to its leadership team: Nurry Hong, Chief Strategy and Business Development Officer; Steve Killmeyer, Chief Financial Officer (CFO); and, Lisa Lucifero, VP, Head of Human Resources. Michael Kaseta, CFO of Liquidia Corporation (Nasdaq: LQKA), has also been appointed to Bryn’s Board of Directors.
Apyx Medical Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for the use of its APR Handpiece in procedures for coagulation of soft tissues following liposuction, the most popular plastic surgery procedure in the world.
RENUVION® RECEIVES FDA CLEARANCE FOR SPECIFIC USE AFTER LIPOSUCTION Read More »
